317 results on '"Eriksen, Erik Fink"'
Search Results
102. Teriparatide Increases Bone Formation in Modeling and Remodeling Osteons and Enhances IGF-II Immunoreactivity in Postmenopausal Women With Osteoporosis
103. Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters
104. Chapter 35 - Validation of Biochemical Markers of Bone Turnover
105. Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures
106. Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
107. A TA Repeat Polymorphism in the Estrogen Receptor Gene Is Associated with Osteoporotic Fractures but Polymorphisms in the First Exon and Intron Are Not
108. Hormone Replacement Therapy Prevents Osteoclastic Hyperactivity: A Histomorphometric Study in Early Postmenopausal Women
109. Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients
110. A new and easier method for the assessment of final erosion depth in cancellous bone
111. New markers of bone metabolism: clinical use in metabolic bone disease
112. Bone changes in metabolic bone disease
113. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics
114. Assessment of erosion depth by lamellar counting
115. Growth Hormone (GH) and Adult Bone Remodeling: The Potential Use of GH in Treatment of Osteoporosis
116. Fluoride stimulates proliferation and differentiation of human marow stromal cells
117. Ultrastructure of human osteoblasts and associated matrix in culture
118. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment
119. Perspective: Remodeling and Vascular Spaces in Bone.
120. Effects of Thyroid Hormones on Bone and Mineral Metabolism
121. Osteoporotic Fractures Are Associated with an 86-Base Pair Repeat Polymorphism in the Interleukin-1-Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin-1β Gene.
122. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.
123. Hormone Replacement Therapy Prevents Osteoclastic Hyperactivity: A Histomorphometric Study in Early Postmenopausal Women
124. 1,25‐dihydroxyvitamin D3potentiates fluoride‐stimulated collagen type I production in cultures of human bone marrow stromal osteoblast‐like cells
125. Histomorphometric Analysis of Bone in Metabolic Bone Disease
126. The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects
127. Bivirkninger av bisfosfonater.
128. Letter to the Editor.
129. Disease-Modifying Adjunctive Therapy of Osteopenia and Osteoporosis with a Multimineral Marine Extract, LithoLexal ® Bone.
130. The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D 3 in monocytes from normal human subjects
131. Thyroid Signaling Biomarkers in Female Symptomatic Hypothyroid Patients on Liothyronine versus Levothyroxine Monotherapy: A Randomized Crossover Trial.
132. Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass.
133. Relationships of serum 25‐hydroxyvitamin D, ionized calcium and parathyroid hormone after obesity surgery.
134. Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
135. Reduced Bone Material Strength is Associated with Increased Risk and Severity of Osteoporotic Fractures. An Impact Microindentation Study.
136. High-sensitivity C-reactive protein is an independent risk factor for non-vertebral fractures in women and men: The Tromsø Study.
137. Excessive Decrease in Serum Magnesium After Total Thyroidectomy for Graves’ Disease Is Related to Development of Permanent Hypocalcemia.
138. Intermittent dosing of zoledronic acid based on bone turnover marker assessment reduces vertebral and non-vertebral fractures.
139. [Vitamin D and COVID-19 – can we draw any final conclusions?]
140. Bone Turnover in Relation to Thyroid-Stimulating Hormone in Hypothyroid Patients on Thyroid Hormone Substitution Therapy.
141. Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study.
142. Disease-Modifying Adjunctive Therapy (DMAT) in Osteoarthritis-The Biological Effects of a Multi-Mineral Complex, LithoLexal ® Joint-A Review.
143. Bone turnover markers in the treatment of osteoporosis.
144. Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study.
145. Evidence of impaired bone quality in men with type 1 diabetes: a cross-sectional study.
146. Bisphosphonates as a treatment modality in osteoarthritis.
147. Relationships Between Vitamin D Status and PTH over 5 Years After Roux-en-Y Gastric Bypass: a Longitudinal Cohort Study.
148. [Estrogens in menopause – time to change the guidelines?].
149. Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.
150. [Re: Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.